Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
about
Current status of biomarker research in neurologyAquaporin-4 autoimmunityB Cells and Autoantibodies in Multiple SclerosisAutoantibodies to MOG in a distinct subgroup of adult multiple sclerosisMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeLongitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life.Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.MOG antibody-associated diseasesGut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens.Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD)Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.Autoimmunity: The good, the bad, and the uglySerum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.CNS accumulation of regulatory B cells is VLA-4-dependent.Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4.MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.Astrocyte barriers to neurotoxic inflammation.The Prevalence of Anti-Aquaporin 4 Antibody in Patients with Idiopathic Inflammatory Demyelinating Diseases Presented to a Tertiary Hospital in Malaysia: Presentation and Prognosis.Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 AutoimmunityThe Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination.Investigation-Directed Approach to Inflammatory Optic Neuropathies.Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates.T cells targeting neuromyelitis optica autoantigen aquaporin-4 cause paralysis and visual system injury.Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.Predictors of outcome in a large retrospective cohort of patients with transverse myelitis.Macular changes of neuromyelitis optica through spectral-domain optical coherence tomography.Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4.A population-based prospective study of optic neuritis.Observations on the evolving fields of neuroimmunology and neuroinflammation.Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.
P2860
Q26744505-149F98C7-5B9C-4513-8C87-AB3FB5D4F95CQ26799559-EBE6CD7E-ADDE-4D7A-A369-42D956823F79Q26801386-F703A996-93E6-4018-ACC2-B831B3B69787Q29036090-17FD885C-A4B1-4780-9CDC-FC2535857E4FQ30371412-144B0120-7C46-4AE2-861D-DBE449395952Q30945169-A1C0CCA1-6C14-4BC3-858B-13E9F22E16BDQ30975717-C918FA3E-72B8-4A5F-87D4-290082549A88Q33719007-40A22F0A-5122-4060-BDD1-7EAB966E29CBQ34513731-5C1ED408-0F68-47EB-AD44-1189DDE1DC0EQ35023345-1D3A8525-0A24-4705-8871-483134E093ADQ36072521-3EE72850-86D7-4A6A-BF5A-FF2C2635B1CBQ36218384-6FF50607-D487-459C-9962-C6129A230B1FQ36359371-BA543C63-4600-400C-93C9-F9B0A6BB9A40Q36359919-17779166-ED68-421A-8FD5-CC9FD44C22A6Q36562604-B06033E1-147D-40D0-A43A-F23B123E5413Q36694494-80FB60A3-C01D-489C-9411-AFD437FEFC0FQ36794719-5AB29647-10BD-4C2B-90BE-E60797699C18Q37274895-8B77CCBF-B67E-479E-9E8A-3690E190406EQ37365089-083F5B09-B7B1-42F9-8180-524055C98A65Q37383474-72FA63D8-D467-409E-AE9C-10EF9B271C52Q37534144-E3B58150-AA38-410B-A869-98077C603CE7Q37590294-59939557-D99B-4BC7-8BD8-F6A965270CAAQ37597818-B2102460-4A1A-4F23-B967-CD38D0FBC540Q37620245-B95D44B7-F393-4796-97AD-573E50784C62Q37661860-B78F1CC2-B77E-4EDE-AD2E-49D986BDE898Q37670455-CE296A9F-CEF1-4887-9817-126FC8ADF7B7Q38714054-F947CF20-EEF8-4007-BFE9-286602143F9DQ38766838-E3EF22A1-3C8A-4566-9E03-03824011451DQ38831970-D7E672C3-B3FB-42C4-9F7B-B3B1571D98DEQ40066335-9BD2A652-94DC-47FE-8205-45C8118E6AF0Q40565668-A9A2212D-E48C-47D8-BA79-8AC60CBDF211Q41098721-F69E5994-4357-469D-9F09-DEBD41E93608Q41106804-4EEB1AE2-D417-4EAF-9A7D-1E9A5B705362Q41992411-31C8881A-C7E7-43B5-ADBE-0C5440E1471DQ42056761-64015C99-AC89-4997-B4E9-38CD218008D4Q42361527-EFEA1087-1809-4179-858D-B384509FFB5EQ42364252-D720FD7C-82DA-478A-8F00-ED1E9BED5902Q42694999-59F15675-1750-47D4-8E56-B92CCAD847FAQ43156877-24C84922-0BE6-4A52-A91F-57FCA61A1B67Q44875571-1D7C17D3-F958-4934-85FB-970B107B74EC
P2860
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Does MOG Ig-positive AQP4-sero ...... osis of NMO spectrum disorder?
@en
type
label
Does MOG Ig-positive AQP4-sero ...... osis of NMO spectrum disorder?
@en
prefLabel
Does MOG Ig-positive AQP4-sero ...... osis of NMO spectrum disorder?
@en
P2860
P1476
Does MOG Ig-positive AQP4-sero ...... osis of NMO spectrum disorder?
@en
P2093
Anthony J Slavin
Scott S Zamvil
P2860
P356
10.1212/NXI.0000000000000062
P577
2015-01-22T00:00:00Z